Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001066

Drug Information
NameBrompheniramine    
Synonymsgamma-(4-Bromophenyl)-N,N-dimethyl-2-pyridinepropanamine; 3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine; 980-71-2 (maleate (1:1)); HSDB 3017; NCGC00089782-02; 2-(p-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine; SPBio_001619; CHEBI:3183; Prestwick3_000475; CHEMBL811; Bromfeniramina; Prestwick0_000475; Spectrum2_001610; NCGC00015146-07; 2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-; KBio3_001861; Oprea1_690847; SPBio_002549; PDSP1_000146; 32188-07-1; KBioSS_002162; Prestwick1_000475; Spectrum_001682; DIMETANE-DX; Spectrum5_001537; 3-(p-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine; Bromfenex; BROMFED-DM; KBio2_007298; Spectrum4_001107; KBio2_004730; KBio2_002162; C06857; L001031; UNII-H57G17P2FN; 3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine; BRD-A68723818-050-05-1; 156428-33-0; LS-187224; BSPBio_002641; p-Bromdylamine; 3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine; AB00053703; [3-(4-Bromophenyl)-3-(2-pyridyl)propyl]dimethylamine; 2-Pyridinepropanamine, .gamma.-(4-bromophenyl)-N,N-dimethyl-; DB00835; BPBio1_000672; AC1L1NEM; Brotane; 86-22-6; CID6834; BROMPHENIRAMINE; Parabromdylamine; D07543; Brompheniramine Maleate (1:1); PDSP2_000145; Brompheniraminum; DivK1c_006846; LS-130308; 2-Pyridinepropanamine, .gamma.-(4-bromophenyl)-N,N-dimethyl-; Brompheniramine (INN); Brompheniramine [INN:BAN]; C16H19BrN2; LS-177900; Bromfeniramina [INN-Spanish]; 2-Pyridinepropanamine, .gamma.-(4-bromophenyl)-N,N-dimethyl-, (S)-; BSPBio_000610; Spectrum3_000981; Prestwick2_000475; KBio1_001790; Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-; STL058559; 1-(p-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane; Lopac0_000201; para-Bromdylamine; SpecPlus_000750; MolPort-005-935-546; KBioGR_001554; EINECS 201-657-8; Brompheniraminum [INN-Latin]; Bromfed; AC-15955; Brotane (TN)    
IndicationAllergic rhinitisApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntiallergic Agents    
CAS NumberCAS 86-22-6
FormularC16H19BrN2    
PubChem Compound IDCID 6834.    
PubChem Substance IDSID 9075.    
SuperDrug ATC IDR06AB01;    
SuperDrug CAS ID000086226;    
TargetHistamine H1 receptorAntagonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 083821 To Reference
Ref 2Histamine-induced venodilation in human beings involves both H1 and H2 receptor subtypes. J Allergy Clin Immunol. 1994 Mar;93(3):606-14. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543